Tuberculosis News and Research

Latest Tuberculosis News and Research

Australian, Singapore researchers join hands to combat disease-causing bugs

The fight against a number of significant infectious diseases in the Asia-Pacific region has been given a boost through a new research collaboration between the National Health and Medical Research Council in Australia and the Agency for Science, Technology and Research in Singapore.

12 Apr 2013

Global health efforts a casualty of across-the-board cuts under 'sequester'

"The across-the-board cuts under the 'sequester' will undermine efficient programs, along with the inefficient. One unfortunate casualty is spending on global health efforts," a Pittsburgh Post-Gazette editorial says.

11 Apr 2013

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, has published Issue 214 of its "Global Fund Observer."

11 Apr 2013

$15B commitment to Global Fund would change the course of history

On Monday "in Brussels, the Global Fund to Fight AIDS, Tuberculosis and Malaria announced an appeal to government and private sector donors for $15 billion for the next three years," Joyce Banda, president of the Republic of Malawi, writes in the Huffington Post's "The Big Push" blog.

11 Apr 2013

Interaction global health briefing book warns of implications from U.S. budget cuts

InterAction, an umbrella group representing 37 non-governmental organizations (NGOs), "is calling on Congress and President Barack Obama's administration to keep spending on global health aid at current levels, warning that recent budget cuts risk a dangerous backslide in health and development gains achieved over the past three decades," Inter Press Service reports.

11 Apr 2013

South Africa announces rollout of new single-dose ARV therapy

"South Africa's Health Minister Aaron Motsoaledi announced on Monday the launch of a new single-dose combination antiretroviral drug that will cost just 89 rand a month ($10) per patient, potentially revolutionizing AIDS treatment in the country," Salon reports (McDonough, 4/9).

11 Apr 2013

Interaction global health briefing provides recommendations to congress, administration

"If the United States does not follow through on global health commitments, there could be a reversal or stagnation of recent gains in reducing maternal deaths and incidences of tuberculosis, malaria, HIV and other diseases in developing countries, warns a report published [Monday]," titled "Global Health: Investing in Our Future," an InterAction press release states.

10 Apr 2013

Study reveals high blood pressure and obesity are no longer confined to wealthy countries

High blood pressure and obesity are no longer confined to wealthy countries, a new study has found. These health risks have traditionally been associated with affluence, and in 1980, they were more prevalent in countries with a higher income.

10 Apr 2013

Five Japanese drug makers form PPP to accelerate development of drugs, vaccines for infectious diseases

"Five Japanese pharmaceutical giants are teaming up with the Bill & Melinda Gates Foundation and Japan's government to develop new medicines, vaccines, and diagnostics for infectious diseases in developing countries," GENNews reports (4/8).

10 Apr 2013

Continued support of Global Fund is worthy investment

Writing in the Huffington Post's "The Big Push" blog, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, examines why the Global Fund to Fight AIDS, Tuberculosis and Malaria is a good investment.

10 Apr 2013

Global Fund aims to raise $15B to fight infectious diseases in 2014-2016 period

"The Global Fund to Fight AIDS, Tuberculosis and Malaria has set the target of raising $15 billion to help countries fight the three infectious diseases in the 2014-2016 period, its Executive Director Mark Dybul said ... on Monday," Xinhua reports.

10 Apr 2013

Research findings could help develop effective vaccines against new strains of bird flu

Scientists have described small genetic changes that enable the H5N1 bird flu virus to replicate more easily in the noses of mammals.

9 Apr 2013

Anacor signs research agreement to discover drug candidates to treat neglected diseases

Anacor Pharmaceuticals today announced that it has signed a research agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to discover drug candidates intended to treat two filarial worm diseases (onchocerciasis, or river blindness, and lymphatic filariasis, commonly known as elephantiasis) and tuberculosis.

9 Apr 2013

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gy-rgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer.

7 Apr 2013

Student coalition ranks research universities' spending and activities on neglected diseases, other illnesses

"A first-time ranking of 54 top research universities in the United States and Canada has found that a miniscule percentage of funding goes to neglected diseases, despite the outsized influence that public universities play in developing medicines for illnesses often ignored by the private sector," Inter Press Service reports.

6 Apr 2013

To meet TB treatment goals, latent TB cases must be diagnosed

"If everyone in the world were tested for latent infection with tuberculosis (a status that predisposes people to develop active disease) today, at least one billion people would be positive," Ray Chambers, U.N. special envoy for health financing, writes in the Huffington Post's "The Big Push" blog.

4 Apr 2013

'Remarkable alignment' of PEPFAR, Global Fund efforts is reason for continued support

Recent global health events -- including the release of PEPFAR's Blueprint for an AIDS-Free Generation (.pdf), the launch of the Global Fund to Fight AIDS, Tuberculosis and Malaria's new funding model, and the Institute of Medicine's evaluation of PEPFAR -- "mak[e] it clear; it is a time of transformation for global health," Deborah Derrick, president of the Friends of the Global Fight Against HIV, Tuberculosis and Malaria, writes in the Huffington Post's "The Big Push" blog.

3 Apr 2013

HAP caused by exposure to biomass fuels increases mortality risk

Almost four million people die each year from household air pollution (HAP) caused by exposure to the combustion of biomass fuels (wood, charcoal, crop residues, and dung), kerosene, or coal.

2 Apr 2013

Washington Post examines HIV, TB epidemics in Russia

The Washington Post examines how the HIV and tuberculosis epidemics are affecting Russia, where "HIV/AIDS was the third-largest cause of premature death," according to recently released data in the Global Burden of Disease Study 2012.

30 Mar 2013

Global Coalition of TB Activists lends voice to international discourse

"The Global Coalition of TB Activists came together at a February Stop TB Partnership meeting in Geneva, [an] announcement says, with the aim of closing gaps that leave those most affected by tuberculosis out of decision making at local, national, and global levels," the Center for Global Health Policy's "Science Speaks" blog reports.

30 Mar 2013

Tuberculosis News and Research

Latest Tuberculosis News and Research

Australian, Singapore researchers join hands to combat disease-causing bugs

Global health efforts a casualty of across-the-board cuts under 'sequester'

Aidspan publishes new issue of 'Global Fund Observer'

$15B commitment to Global Fund would change the course of history

Interaction global health briefing book warns of implications from U.S. budget cuts

South Africa announces rollout of new single-dose ARV therapy

Interaction global health briefing provides recommendations to congress, administration

Study reveals high blood pressure and obesity are no longer confined to wealthy countries

Five Japanese drug makers form PPP to accelerate development of drugs, vaccines for infectious diseases

Continued support of Global Fund is worthy investment

Global Fund aims to raise $15B to fight infectious diseases in 2014-2016 period

Research findings could help develop effective vaccines against new strains of bird flu

Anacor signs research agreement to discover drug candidates to treat neglected diseases

A*STAR's professor receives Szent-Gy-rgyi prize for groundbreaking cancer pill

Student coalition ranks research universities' spending and activities on neglected diseases, other illnesses

To meet TB treatment goals, latent TB cases must be diagnosed

'Remarkable alignment' of PEPFAR, Global Fund efforts is reason for continued support

HAP caused by exposure to biomass fuels increases mortality risk

Washington Post examines HIV, TB epidemics in Russia

Global Coalition of TB Activists lends voice to international discourse

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Tuberculosis News and Research

Latest Tuberculosis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in